UltraSight

UltraSight is a digital health company focused on AI-powered cardiac ultrasound technology. Its mission is to enhance cardiac care by making high-quality ultrasound imaging accessible to healthcare providers, regardless of their sonography expertise. The company simplifies cardiac ultrasound acquisition, enabling timely and accurate imaging in various clinical settings, including emergency departments and general practitioner offices. The flagship product is an AI-driven real-time guidance software that assists medical professionals in performing cardiac ultrasound scans with greater accuracy. This technology increases access to point-of-care cardiac ultrasound, improving patient triage and treatment efficiency. UltraSight has achieved significant regulatory milestones, including FDA 510(k) clearance and CE Mark approval, allowing it to market its technology internationally. The leadership team includes experienced professionals from technology and medicine, and the company serves hospitals, urgent care centers, and healthcare providers looking to enhance their cardiac diagnostic capabilities. UltraSight aims to democratize access to cardiac ultrasound and improve patient outcomes through its innovative imaging solutions.

• Employees 39
• Founded 2018
• Total Funding $13000000